Abstract
Patients with systemic lupus erythematosus (SLE) are at great risk of bacterial infection because of immune system dysregulation and immunosuppressive treatment. Urinary tract and bloodstream infections are some of the most frequent complications, with high morbidity. The objective of this study was to determine the etiological agents defined and associated with urine and blood samples of patients with SLE and characterize them. A total of 110 urine and 8 blood samples were taken from patients with SLE who appeared at the hospital between March and August 2024. Cultures were handled according to standard microbiological methods, and bacterial strains were identified using Gram staining, biochemistry techniques, and VITEK $4 automated equipment. Blood samples: Gram-positive had a marginal predominance (50%), and Escherichia coli 3 (37.5%) was the commonest isolate, followed by Staphylococcus aureus 2 (25%), K pneumoniae 1 (12.5%), P aeruginosa 1 (12.5%), and Enterococcus faecalis 1 (12.5%). Conclusion: The epidemiology of both UTIs and BSIs, whether about Gram status or species, is mixed, with Escherichia coli and Staphylococcus aureus as the most common overall isolates among SLE patients. Prompt identification and optimal antibiotic treatment are important for minimizing morbidity and preventing major complications in this immunocompromised population.